Lung Cancer


We have Ranked, Sorted and Summarized the Latest Clinical Articles with Full Text Available.

1Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapyAnnals of Oncology, October 08, 2012  Full Text  Clinical Article
2Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphomaAnnals of Oncology, October 08, 2012  Full Text
3Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, 3, in Patients with Metastatic MelanomaClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
4A Phase I Dose Esclation Study of Tivantinib in Adult Pts w Metastatic Solid TumorsClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
5Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258)-an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors-in Patients with Advanced MelanomaClinical Cancer Research, October 08, 2012  Full Text  Clinical Article
6Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends SurvivalAnnals of Thoracic Surgery, October 08, 2012  Full Text
7HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDSBlood, October 08, 2012  Full Text
8Pam50 breast cancer subtyping by RT-QPCR and concordance with standard clinical molecular markersBMC Genomics, October 08, 2012  Full Text
9Breast vibro-acoustography: initial results show promiseBreast Cancer Research, October 08, 2012  Full Text
10Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomesBreast Cancer Research, October 08, 2012  Full Text

Show Me:

We have Ranked, Sorted and Summarized the Latest Clinical Articles with Full Text Available.

1PNAS: Natural selection not just mutation drives development of cancerUniversity of Colorado Health News, July 28, 2015
2Researchers discover a peptide that inhibits tumor progression in breast cancerIDIBELL-Bellvitge Biomedical Research Institute News, July 28, 2015
3Common chemicals may act together to increase cancer risk, study findsOregon State University News, July 28, 2015
4Researchers discover a possible reason for drug resistance in breast tumorsGerman Cancer Research Center News, July 28, 2015
5Mac researcher finds additional radiation reduces breast-cancer recurrence for some patientsMcMaster University Faculty of Health Sciences News, July 28, 2015
6Study shows targeting bacteria causing ulcers may prevent stomach cancerMcMaster University Faculty of Health Sciences News, July 28, 2015
7Modified DNA building blocks are cancer's achilles heelLudwig Institute for Cancer Research News, July 28, 2015
8Access denied: Leukemia thwarted by cutting off link to environmental supportUC San Diego Health System, July 28, 2015
9FDA approves new treatment for most common form of advanced skin cancerFDA Press Announcements, July 28, 2015
10Using low-dose irradiation, researchers can now edit human genesCedars-Sinai, July 28, 2015

Show Me:

CHD7 associated with survival in pancreatic ductal adenocarcinoma patients receiving gemcitabine

As reported in Cancer Research, low CHD7 expression is associated with increased RFS and OS in pancreatic ductal adenocarcinoma patients receiving gemcitabine. There was no association between CHD7 expression and RFS or OS in patients who were not treated with gemcitabine.

VPAC1 overexpression associated with colon cancer aggression

As reported in Tumor Biology, VPAC1 expression is increased in poorly differentiated compared to well-differentiated colon cancer. VPAC1 expression is also increased in the blood vessels and macrophages adjacent to colon cancer tissues compared to healthy tissues. The overexpression of VPAC1 is related to EGFR overexpression.

CTC count predicts survival in mBC

As reported in The Lancet Oncology, circulating tumor cell (CTC) quantification in patients (20 studies; n = 1944) with metastatic breast cancer (mBC) predicts progression-free survival (PFS) and overall survival (OS), especially when coupled with clinicopathologic data. A CTC count ≥ 5/7.5 mL at baseline is associated with decreased PFS (HR = 1.92) and OS (HR = 2.78). An elevated CTC count 3-5 weeks and 6-8 weeks after treatment commences is also associated with decreased PFS (HR = 1.85 and 2.20) and OS (HR = 2.26 and 2.91).

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocPseudocapsule is most commonly found in the clear cell renal carcinoma subtype.

Clinical Pearl from Smartest DocSelenium supplementation in men with high selenium increases the risk of high-grade PCa by 91%.

Clinical Pearl from Smartest DocWeekly antimitotic inhibitor therapy plus gemcitabine may have an improved overall response rate and toxicity profile compared to 3-times weekly dosing as a second-line chemotherapy option in metastatic breast cancer patients.

Clinical Articles in Oncology

MDLinx Oncology and Cancer News

Search today's latest oncology and hematology news, updated daily from over 2,000 peer-reviewed journals, at MDLinx. Stay current with up-to-the-minute oncology information and cancer related clinical research covering all aspects of cancerous tumors. Our diligent team of MDLinx physician editors rigorously research a wide range of oncology medical journals dedicated to surgery, chemotherapy, radiotherapy and all forms of breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. They then summarize and rank the articles by clinical impact to provide the most valuable literature to make sure any oncologist and all members of their healthcare team can stay current with the latest oncology topics, symptoms, treatments, risk factors and clinical research.